| Catalog Number |
RMT311417 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Code |
Aneurysm (1708)
|
| Date of Event |
08/27/2018
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Additional devices implanted and/or related to this event: pxc201400/9437286 udi (b)(4).The review of the manufacturing paperwork verified that these lots met all pre-release specifications.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2011, the patient was implanted with a gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.It was reported computed tomography images (date unknown), revealed there is a proximal type i endoleak with aneurysm sac enlargement.There is also enlargement of the left common iliac artery aneurysm (treated area) and a distal type i endoleak (previously implanted pxc201400/9437286).Possible reintervention on (b)(6) 2018.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2011, the patient was implanted with a gore® excluder® aaa endoprostheses to treat an abdominal aortic aneurysm.It was reported computed tomography images dated (b)(6) 2018, revealed there is a proximal type i endoleak with aneurysm sac enlargement.There is also enlargement of the left common iliac artery aneurysm (treated area) and a distal type i endoleak (previously implanted pxc201400/9437286).The physician reintervened on (b)(6) 2018, and three additional devices were implanted (ceb231210a/17637894, pla360400/15075132, and plc231000/17837814).The endoleak was resolved and the patient tolerated the reintervention.
|
| |
|
Additional Manufacturer Narrative
|
|
Addition d11: patient medications: amiodarone, aspirin, carvedilol, clopidogrel, coreg, coumadin, levothyroxine, nitroglycerin, rosuvastatin.
|
| |
|
Search Alerts/Recalls
|